Our group is focused on the molecular and translational research of several cancers including those of the prostate, the endometrium, the ovary, the pancreas as well as the pediatric neuroblastoma and rhabdomyosarcoma. We aim to identify and characterize new molecules which might play relevant roles in the neoplastic cell transformation, and/or growth, progression or dissemination of those tumors. All of our projects are based on unresolved clinical needs. Using experimental models, we develop new research strategies that could lead to preclinical validation. We are also studying several molecules of extracellular matrix and their roles in tissue injury and reparation as well as their interactions with biomaterials. Our final aim is to identify new and valuable molecules and biomarkers to improve diagnosis, prognosis and therapy.
